157
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Fracture Rates in Children with Cerebral Palsy: A Danish, Nationwide Register-Based Study

ORCID Icon, ORCID Icon, , , , ORCID Icon, , & ORCID Icon show all
Pages 1405-1414 | Received 21 Jul 2022, Accepted 18 Oct 2022, Published online: 22 Nov 2022

References

  • Simm PJ, Biggin A, Zacharin MR, et al. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health. 2018;54(3):223–233. doi:10.1111/jpc.13768
  • Henderson R, Lark R, Gurka M. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics. 2002;110:e5–e5. doi:10.1542/peds.110.1.e5
  • Stevenson RD, Conaway M, Barrington JW, Cuthill SL, Worley G, Henderson RC. Fracture rate in children with cerebral palsy. Pediatr Rehabil. 2006;9(4):396–403. doi:10.1080/13638490600668061
  • Henderson RC, et al. Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol. 1997;37(4):224–227. doi:10.1111/j.1469-8749.1997.tb07415.x
  • Uddenfeldt Wort U, Nordmark E, Wagner P, Düppe H, Westbom L. Fractures in children with cerebral palsy: a total population study. Dev Med Child Neurol. 2013;55(9):821–826. doi:10.1111/dmcn.12178
  • Presedo A, Dabney KW, Miller F. Fractures in patients with cerebral palsy. J Pediatr Orthop. 2007;27(2):147–153. doi:10.1097/BPO.0b013e3180317403
  • Bouxsein ML, Eastell R, Lui LYY, et al. Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res. 2019;34(4):632–642. doi:10.1002/jbmr.3641
  • Henderson RC, Berglund LM, May R, et al. The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy. J Bone Miner Res. 2010;25(3):520–526. doi:10.1359/jbmr.091007
  • Bianchi ML, Colombo C, Assael BM, et al. Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate. Lancet Respir Med. 2013;1(5):377–385. doi:10.1016/S2213-2600(13)70064-X
  • Vestergaard P. Epilepsy, osteoporosis and fracture risk - A meta-analysis. Acta Neurol Scand. 2005;112(5):277–286. doi:10.1111/j.1600-0404.2005.00474.x
  • Leet AI, Mesfin A, Pichard C, et al. Fractures in children with cerebral palsy. J Pediatr Orthop. 2006;26:624–627. doi:10.1097/01.bpo.0000235228.45539.c7
  • Ozel S, Switzer L, Macintosh A, Fehlings D. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update. Dev Med Child Neurol. 2016;58(9):918–923. doi:10.1111/dmcn.13196
  • Hurley T, Zareen Z, Stewart P, McDonnell C, McDonald D, Molloy E. Bisphosphonate use in children with cerebral palsy. Cochrane Database Syst Rev. 2021;2021:7.
  • Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):1–22. doi:10.1371/journal.pmed.1001885
  • Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
  • Uldall P, Michelsen SI, Topp M, Madsen M. The Danish cerebral palsy registry. A registry on a specific impairment. Dan Med Bull. 2001;48(3):161–163.
  • Topp M, Langhoff-Roos J, Uldall P. Validation of a cerebral palsy register. J Clin Epidemiol. 1997;50(9):1017–1023. doi:10.1016/S0895-4356(97)00102-9
  • Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
  • Methodology WCC for DS. ATC Classification Index with DDDs. Methodology WCC for DS; 2022.
  • Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46(3):798. doi:10.1093/ije/dyw213
  • Rasmussen HM, Nordbye-Nielsen K, Møller-Madsen B, et al. The Danish cerebral palsy follow-up program. Clin Epidemiol. 2016;8:457–460. doi:10.2147/CLEP.S99474
  • Tiderius CJ, Landin L, Düppe H. Decreasing incidence of fractures in children: an epidemiological analysis of 1673 fractures in Malmö, Sweden, 1993–1994. Acta Orthop Scand. 1999;70(6):622–626. doi:10.3109/17453679908997853
  • Christensen J, Vestergaard M, Olsen J, Sidenius P. Validation of epilepsy diagnoses in the Danish National Hospital Register. Epilepsy Res. 2007;75(2–3):162–170. doi:10.1016/j.eplepsyres.2007.05.009
  • Hoei-Hansen CE, Laursen B, Langhoff-Roos J, Rackauskaite G, Uldall P. Decline in severe spastic cerebral palsy at term in Denmark 1999–2007. Eur J Paediatr Neurol. 2019;23(1):94–101. doi:10.1016/j.ejpn.2018.08.010